483
Invitrx Therapeutics Inc.FDA 483 - Invitrx Therapeutics Inc. - April 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Invitrx Therapeutics Inc., an HCT/P manufacturer in Lake Forest, CA, was cited for significant deficiencies across its operations. The inspection revealed widespread failures in donor eligibility determination, manufacturing procedures, quality control, record keeping, and equipment maintenance. These issues indicate a severe lack of control over critical processes, posing risks to product safety and integrity.
Open in Dashboard
ID · 8e20c736-81a1-4164-ad17-4d5883461c2d